Galenica to acquire U.S. biopharma firm Relypsa for $1.53 bln in cash

July 21 (Reuters) - Galenica said it has agreed to

buy U.S. biopharma company Relypsa for $1.53 billion in

cash to strengthen its Vifor Pharma unit.

Read more